Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Alnylam Moves Forward on Multi-Product RNAi Facility

August 04, 2016

Jacobs Engineering Group was awarded a contract to provide engineering services and procurement for Alnylam Pharmaceuticals’ new manufacturing facility in Norton, Massachusetts.

Designing Flexible Aseptic Containment Systems

August 02, 2016

The design of Baxter BioPharma Solutions’ aseptic filling lines provides a case study in customizing containment systems for multi-product lines

Using 3D Printing for Solid-Dosage Drugs

August 02, 2016

Three-dimensional printing allows unique benefits to be built in to solid-dosage forms.

Evaluating Technology and Innovation in Biopharmaceutical Manufacturing

August 02, 2016

A technology management process identifies and evaluates new technologies in biopharmaceutical manufacturing to aid business decisions.

FDA and the Emerging Technology of 3D Printing

August 02, 2016

A Q&A with FDA to gain insight on FDA's views of three-dimensional printing and its regulation in drug manufacturing.

Measuring Equipment and Manufacturing Trends

August 02, 2016

PharmTech’s 2016 survey shows general satisfaction with existing solid-dose and parenteral manufacturing equipment, and slow adoption of continuous manufacturing processes.

An Interview with Aprecia about ZipDose Technology

August 02, 2016

Portable Device Delivers Biopharmaceuticals on Demand

August 01, 2016

An MIT-developed system uses microbes for manufacturing small amounts of vaccines and other therapies.

Debating the Role of RABS and Isolators in Aseptic Manufacturing

August 01, 2016

While isolators may offer advantages in high-speed commercial manufacturing lines, RABS continues to be a flexible alternative solution for small-scale production of drugs for clinical use.

Amgen: Neulasta Safe for Now; Dose Accuracy of Erenumab a New Focus

July 28, 2016

Amgen discussed the drug-delivery approaches to two of its biologics in a recent second-quarter earnings call.